Physician profile
Stephen E Mcintyre
NPI 1710943071
$56,857.36
in general payments reported to CMS, 2019-2025
31 companies · $4,160 in 2025
The $4,160 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $4,932 · 2021: $3,970 · 2022: $6,802 · 2023: $13K · 2024: $1,567 · 2025: $4,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,194 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,775 · Travel and Lodging: $4,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,194.03 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,775.00 |
| Travel and Lodging | $4,935.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $26,684.74 | 2019-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $10,214.75 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $7,840.07 | 2019-2025 | Amplatzer Amulet, Triclip, Aveir |
| Medtronic, INC. | $5,623.29 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Edwards Lifesciences Corporation | $2,327.73 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $1,471.19 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $1,008.50 | 2020-2025 | Impella |
| Biosense Webster, INC. | $281.63 | 2021-2024 | Nuvision Ice Catheter, Na, Soundstar |
| Medtronic Vascular, INC. | $223.18 | 2019-2020 | |
| Terumo Medical Corporation | $191.28 | 2019-2025 | Navicross |
| Atricure, INC. | $154.70 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $149.07 | 2019-2025 | |
| Pfizer INC. | $119.27 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $102.42 | 2024-2025 | Assure Wcd |
| Heartflow, INC. | $68.33 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $38.85 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.66 | 2021 | |
| Novo Nordisk INC | $33.81 | 2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $33.11 | 2019-2022 | |
| Cardinal Health 200 LLC | $28.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $26.96 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $26.70 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Regeneron Healthcare Solutions, INC. | $25.61 | 2019 | |
| Penumbra, INC. | $23.70 | 2024 | Indigo System |
| Sobi, INC | $22.46 | 2021 | |
| Acist Medical Systems, INC. | $20.50 | 2022 | |
| Agepha Pharma Fz LLC | $18.51 | 2025 | Lodoco |
| Irhythm Technologies, INC. | $18.21 | 2024 | Zio Monitor, Zio Xt Patch |
| Genzyme Corporation | $15.56 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.23 | 2024 | Lifevest |
| Teleflex LLC | $14.90 | 2025 | Turnpike |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$20.87 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.